Letters
Treatments for paracetamol poisoning
Guidance on acetylcysteine for paracetamol ingestion needs review
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3455 (Published 28 June 2016) Cite this as: BMJ 2016;353:i3455- Simon H L Thomas, professor of clinical pharmacology and therapeutics1,
- D Nicholas Bateman, honorary professor in clinical toxicology2,
- James W Dear, reader in clinical pharmacology2
- 1Medical Toxicology Centre, Newcastle University, Newcastle NE2 4HH, UK
- 2Pharmacology, Toxicology and Therapeutics, University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh
- simon.thomas{at}ncl.ac.uk
Buckley and colleagues highlight differences in international guidance for treating acute paracetamol poisoning.1 Following recommendations by the Commission on Human Medicines (CHM), the UK uses lower thresholds for acetylcysteine use than almost all other countries, treating many more patients at low risk of toxicity. Anaphylactoid reactions are further increased, as these are more common in patients with …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.